Hopefully this test is accurate and widely available soon:
>>>The FDA has authorized its first rapid, point-of-care diagnostic for the novel coronavirus—allowing physicians in hospitals, clinics and emergency rooms to test a sample for the disease in about 45 minutes.
Developed by Cepheid, the test is built to run on its automated GeneXpert hardware, with more than 23,000 tabletop systems installed worldwide and over 5,000 in the U.S., according to the company. . . .
With the FDA's emergency use authorization in hand, the company said it plans to begin shipping the test this week, and is concurrently pursuing its approval in Europe.<<<
The FDA has authorized its first rapid, point-of-care diagnostic for the novel coronavirus—allowing physicians in hospitals, clinics and emergency rooms to test a sample for the disease i | The FDA has authorized its first rapid, point-of-care diagnostic for the novel coronavirus—allowing...
www.fiercebiotech.com